FDA Panel Rejects MDMA for PTSD Amid Safety and Methodology Concerns In The Trials
An FDA advisory panel has recommended against approving MDMA for PTSD treatment, citing significant concerns about the safety and methodological
Read more
MDMA
Australia Becomes First to Reclassify MDMA and Psilocybin As Medicine for Specific Uses
Australia has become the first country in the world to re-classify the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) as medicines.
Read more